What Does CJC-1295 + Ipamorelin Dissolve In? Solvents Explained
Solubility behaviour is where compounds in this library differ most sharply from one another. For CJC-1295 + Ipamorelin, the determining factors are structural: combination — ghrh(1-29) analogue plus selective ghrelin-receptor agonist.
In plain English
Straightforward. Both components are water-friendly and go into solution together. The complication with blends is never dissolving, it is knowing what proportion of what you actually have.
What CJC-1295 + Ipamorelin actually is
This is a blend of two separate molecules rather than one. CJC-1295 is a shortened version of the natural growth hormone signal with four amino acids swapped for resistance. Ipamorelin works through a completely different receptor. They are paired because they reach the same result by two independent routes.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
How CJC-1295 + Ipamorelin behaves in solution
Both components are water-soluble and dissolve together in a single diluent volume without difficulty. Because this is a blend, the reconstituted concentration figure refers to combined peptide mass unless the label specifies a per-component split — worth confirming before calculating.
Suitable solvents, in order
Structural basis
CJC-1295 + Ipamorelin is combination — ghrh(1-29) analogue plus selective ghrelin-receptor agonist. This is a two-compound blend studied for complementary mechanisms rather than a single molecule. CJC-1295 is a modified GHRH(1-29) fragment with four amino-acid substitutions that resist enzymatic degradation. Ipamorelin is a pentapeptide ghrelin-receptor agonist notable for its selectivity — it was specifically developed to stimulate GH release without the cortisol and prolactin effects of earlier secretagogues like GHRP-6.
What CJC-1295 + Ipamorelin is studied for
GHRH-receptor and ghrelin-receptor agonism act through different mechanisms, which is the rationale for pairing them.
Developed specifically for GH release with minimal cortisol and prolactin effects — its defining pharmacological feature.
Studied for effects on the pattern of GH secretion rather than continuous elevation.
A common endpoint in the preclinical literature for GH-axis compounds.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More CJC-1295 + Ipamorelin reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Solubility reference for other compounds
CJC-1295 + Ipamorelin is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.